Simplified Equations Using Two Concentrations To Calculate Area under the Curve for Antimicrobials with Concentration-Dependent Pharmacodynamics: Daptomycin as a Motivating Example
暂无分享,去创建一个
M. Falcone | M. Venditti | A. Novelli | A. Russo | M. Pai
[1] K. Rodvold,et al. Aminoglycoside dosing in patients by kidney function and area under the curve: the Sawchuk-Zaske dosing method revisited in the era of obesity. , 2014, Diagnostic microbiology and infectious disease.
[2] M. Bassetti,et al. Daptomycin underexposure in a young intravenous drug user who was affected by life-threatening Staphylococcus aureus-complicated skin and soft tissue infection associated with bacteraemia , 2014, Infection.
[3] F. D. De Rosa,et al. Development and validation of an UPLC-PDA method to quantify daptomycin in human plasma and in dried plasma spots. , 2014, Journal of pharmaceutical and biomedical analysis.
[4] M. Falcone,et al. Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] Guan-Yuan Chen,et al. Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography-tandem mass spectrometry. , 2013, Talanta.
[6] J. Roberts,et al. Clinical implications of antibiotic pharmacokinetic principles in the critically ill , 2013, Intensive Care Medicine.
[7] M. Karlsson,et al. Population pharmacokinetics of daptomycin in patients affected by severe Gram-positive infections. , 2013, International journal of antimicrobial agents.
[8] Roland Jw Meesters,et al. State-of-the-art dried blood spot analysis: an overview of recent advances and future trends. , 2013, Bioanalysis.
[9] G. Drusano,et al. Dosing Regimen Matters: the Importance of Early Intervention and Rapid Attainment of the Pharmacokinetic/Pharmacodynamic Target , 2012, Antimicrobial Agents and Chemotherapy.
[10] F. Pea,et al. TDM-Guided Therapy with Daptomycin and Meropenem in a Morbidly Obese, Critically Ill Patient , 2011, The Annals of pharmacotherapy.
[11] G. Drusano,et al. Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] R. H. Baltz,et al. Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] J. Norenberg,et al. Influence of Morbid Obesity on the Single-Dose Pharmacokinetics of Daptomycin , 2007, Antimicrobial Agents and Chemotherapy.
[14] M. Barclay,et al. A suggested approach to once-daily aminoglycoside dosing. , 1995, British journal of clinical pharmacology.
[15] R W Jelliffe,et al. Modeling, adaptive control, and optimal drug therapy. , 1990, Medical progress through technology.
[16] R. Sawchuk,et al. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: Gentamicin in burn patients , 1976, Journal of Pharmacokinetics and Biopharmaceutics.
[17] G. d’Ettorre,et al. Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary? , 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[18] J. Roberts,et al. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock. , 2011, Critical care clinics.
[19] Sara E Cosgrove,et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] D. Levine,et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.